Dean J. Kramer

Array ( [id] => 3949478 [patent_doc_number] => 05955429 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Human apoptosis-associated protein' [patent_app_type] => 1 [patent_app_number] => 9/213398 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18334 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955429.pdf [firstpage_image] =>[orig_patent_app_number] => 213398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420218 [patent_doc_number] => 06194550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Systematic polypeptide evolution by reverse translation' [patent_app_type] => 1 [patent_app_number] => 9/197649 [patent_app_country] => US [patent_app_date] => 1998-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21688 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194550.pdf [firstpage_image] =>[orig_patent_app_number] => 197649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181159 [patent_doc_number] => 06150150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Human brain phosphodiesterase' [patent_app_type] => 1 [patent_app_number] => 9/192702 [patent_app_country] => US [patent_app_date] => 1998-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 14464 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150150.pdf [firstpage_image] =>[orig_patent_app_number] => 192702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420710 [patent_doc_number] => 06503500 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Biocontrol agent containing an endotoxin gene' [patent_app_type] => B1 [patent_app_number] => 09/147259 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2251 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503500.pdf [firstpage_image] =>[orig_patent_app_number] => 09147259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4317329 [patent_doc_number] => 06248543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Compositions and methods for screening antimicrobials' [patent_app_type] => 1 [patent_app_number] => 9/184826 [patent_app_country] => US [patent_app_date] => 1998-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16011 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248543.pdf [firstpage_image] =>[orig_patent_app_number] => 184826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1573803 [patent_doc_number] => 06468523 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Polypeptide compositions toxic to diabrotic insects, and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/184748 [patent_app_country] => US [patent_app_date] => 1998-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 51948 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468523.pdf [firstpage_image] =>[orig_patent_app_number] => 09184748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1164621 [patent_doc_number] => 06756212 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/174937 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 12 [patent_no_of_words] => 42052 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756212.pdf [firstpage_image] =>[orig_patent_app_number] => 09174937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404154 [patent_doc_number] => 06264953 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception' [patent_app_type] => 1 [patent_app_number] => 9/169119 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 12016 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/264/06264953.pdf [firstpage_image] =>[orig_patent_app_number] => 169119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7623706 [patent_doc_number] => 06686459 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/163099 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 11573 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686459.pdf [firstpage_image] =>[orig_patent_app_number] => 09163099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1449750 [patent_doc_number] => 06455304 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Hyaluronate synthase gene and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/146893 [patent_app_country] => US [patent_app_date] => 1998-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 22433 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455304.pdf [firstpage_image] =>[orig_patent_app_number] => 09146893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347278 [patent_doc_number] => 06583108 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Human bikunin' [patent_app_type] => B1 [patent_app_number] => 09/144428 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 42 [patent_no_of_words] => 31256 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583108.pdf [firstpage_image] =>[orig_patent_app_number] => 09144428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 698339 [patent_doc_number] => 07067250 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-27 [patent_title] => 'Extracellular serine protease' [patent_app_type] => utility [patent_app_number] => 09/137944 [patent_app_country] => US [patent_app_date] => 1998-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 10733 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067250.pdf [firstpage_image] =>[orig_patent_app_number] => 09137944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440240 [patent_doc_number] => 06495519 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Interleukin-1 converting enzyme like apoptosis protease-3 and 4' [patent_app_type] => B1 [patent_app_number] => 09/124934 [patent_app_country] => US [patent_app_date] => 1998-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11196 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495519.pdf [firstpage_image] =>[orig_patent_app_number] => 09124934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1395251 [patent_doc_number] => 06531298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-11 [patent_title] => 'Factor IX antihemophilic factor with increased clotting activity' [patent_app_type] => B2 [patent_app_number] => 09/118748 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6125 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531298.pdf [firstpage_image] =>[orig_patent_app_number] => 09118748 [rel_patent_id] =>[rel_patent_doc_number] =>)